First human tests for experimental drug begin
NCT ID NCT06007638
Summary
This early-stage study tested the safety of a new drug called LY3876602 in 74 healthy volunteers. Researchers gave participants increasing doses to see how well the drug was tolerated and measured how much entered the bloodstream and spinal fluid. The main goal was to understand the drug's safety profile and how the body processes it before testing in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON Early Phase Services, LLC
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.